Vidcast: https://www.instagram.com/p/DW4k7LQkQlT/

University of Pittsburgh ophthalmologists now announce the first human implantations of wireless retinal devices that restore vision for those with advanced age-related macular degeneration. And the implant is the size of a grain of rice.

The researchers report that 81% of patients regain meaningful central vision. More than 80% can read letters and even words once again. On average, patients enjoy a five line vision improvement when tested with standard eye charts. Some participants noted even better improvement with one subject able to discern the letters in 12 lines further down the chart.

So how does the device work? A 2 millimeter square wireless retinal chip replaces damaged light-sensing cells in the eye. Special camera-containing eyewear captures images and send signals to a processor and from there to the implant using near-infrared light. The implant, in turn, stimulates surviving retinal cells that send visual information to the brain.

While this implant doesn’t restore perfect 20/20 vision yet, it helps once-blind people read numbers, words, and even pages of text once again.

Age-related macular degeneration is a leading cause of blindness worldwide, affecting more than 5 million people. This technology could represent a major step toward restoring vision for many of them……someday soon

The references for this report are available on my website.

#MacularDegeneration #VisionResearch #BlindnessTreatment #MedicalInnovation #Futuremed

Vidcast: https://www.instagram.com/p/DW4kRHtCTQ9/

Medical teams might one day diagnose serious brain diseases without a brain scan or spinal tap.

Scientists have developed a new test that analyzes tiny structural changes in brain-related proteins found in saliva. This according to Korean study published in the journal Advanced Materials.

Using special nanomaterials made of gold and copper oxide, the system amplifies extremely weak biological signals more than a billion times, allowing them to be detected.

Artificial intelligence then analyzes these signals to identify patterns linked to neurological diseases.

In early testing with patients, the technology identified Parkinson’s disease, epilepsy, and schizophrenia with accuracy above 90%—reaching up to 98%.

Currently, the diagnosis of many neurological diseases requires expensive brain imaging and spinal fluid tests. This simple saliva test makes screening faster, cheaper, and far less invasive, potentially allowing doctors to detect problems much earlier…..someday soon.

The references for this report are available on my website.

#BrainHealth #NeurologyResearch #EarlyDetection #MedicalInnovation #FutureMedicine

Vidcast: https://www.instagram.com/p/DW4joMAlrUw/

Cardiologists at Texas A&M are developing a one-shot therapy that could help your heart recover during the weeks following a heart attack.

The treatment uses self-amplifying RNA (saRNA), a technology similar to that used in some modern vaccines. After a simple injection into your arm muscle, your cells temporarily receive instructions to produce more of a natural heart-protective hormone called ANP.

Here’s why that helps:

• ANP helps reduce stress on the heart.

• It limits tissue damage and scarring.

• It supports healing during the critical recovery window.

Because the RNA instruction molecule copies itself, one injection keeps the ANP hormone circulating for several weeks, helping your heart repair itself during the most vulnerable and dangerous period.

Preclinical research shows self-amplifying RNA improves heart healing and protects vulnerable heart muscle after a heart attack. Critical human trials are still ahead. If they confirm these results, doctors could one day give one shot to help your heart recover more effectively following a heart attack.

References On My Website.

#HeartHealth #HeartAttackRecovery #MedicalBreakthrough #RNAtherapy #CardiologyResearch